Seres Therapeutics, Inc. - 8-K Filing
On May 30, 2026, Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a member of the board of directors of Seres Therapeutics, Inc., effective May 31, 2026; Dr. Woerle's departure is not due to any disagreements with the company. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Offi)
Tickers: $MCRB